Vinge represents Altor in connection with its investment in H2 Green Steel. The investment has been carried out in connection with 1.5 billion euro investment round in H2 Green Steel. Investors participating in the capital raise included, in addition to Altor, inter alia AMF, GIC, Hitachi Energy, Kinnevik, Schaeffler, Andra AP-fonden, FAM, Hy24 and Just Climate.

H2 Green Steel was founded in 2020 with the ambition to accelerate the decarbonization of hard-to-abate industries. The company is starting with steel, which is one of the world’s largest carbon dioxide emitters, building a plant in Boden, northern Sweden. The plant will produce green steel, reducing CO2 emissions with up to 95 percent compared to traditional steelmaking. Groundwork has been in progress at the Boden site since the summer of 2022, and with this transaction, H2 Green Steel is taking a significant step closer to commencing operations by the end of 2025.

Vinge's team consisted mainly of Johan Larsson, Isabelle Wållgren, Robin Fagerström (M&A), Christoffer Nordin, Jolene Reimerson, Elis Allmark (Commercial Agreements), Johan Cederblad, Lina Österberg (Environment), Kristoffer Larson (Real Estate), Mathilda Persson (IT), Mia Falk, Julia Löfqvist (Compliance), Louise Brorsson Salomon, Helena Göransson, Kamyar Najmi (Banking and Finance), Axel Lennartsson (IP), Johan Wahlbom (Competition law), Daniel Wendelsson (Regulatory), Emy Rydén and Ottilia Pettersson (project assistants).

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025